» Authors » Francesco A Mistretta

Francesco A Mistretta

Explore the profile of Francesco A Mistretta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 90
Citations 447
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferro M, Tataru O, Fallara G, Fiori C, Manfredi M, Claps F, et al.
Minerva Urol Nephrol . 2024 Dec; PMID: 39625636
Background: Approximately 70% of bladder cancer is diagnosed as non-muscle invasive (NMIBC) and inflammation is known to impact the oncological outcomes. Adjuvant intravesical BCG in intermediate/high risk can lower recurrence...
2.
Jannello L, de Angelis M, Siech C, Di Bello F, Penaranda N, Tian Z, et al.
Minerva Urol Nephrol . 2024 Nov; PMID: 39494945
Background: The aim of this study was to validate lymphovascular invasion (LVI) as a predictor of lymph-node invasion (LNI) in squamous cell carcinoma of the penis (SCCP). Methods: Within the...
3.
Jannello L, Siech C, Baudo A, de Angelis M, Di Bello F, Goyal J, et al.
Minerva Endocrinol (Torino) . 2024 Sep; PMID: 39345031
Background: The use of inpatient palliative care (IPC) in advanced cancer patients represents a well-established guideline recommendation. This study examines the utilization rates and patterns of IPC among patients with...
4.
Jannello L, Orsi F, Luzzago S, Mauri G, Mistretta F, Piccinelli M, et al.
BJU Int . 2024 Sep; 135(1):156-165. PMID: 39290073
Objective: To conduct a comprehensive comparison of microwave ablation (MWA) vs radiofrequency ablation (RFA) outcomes in the treatment of small renal masses (SRMs), specifically: TRIFECTA ([i] complete ablation, [ii] absence...
5.
Piccinelli M, Garcia C, Panunzio A, Tappero S, Barletta F, Incesu R, et al.
J Surg Oncol . 2024 Aug; 130(8):1683-1690. PMID: 39183540
Purpose: It is unknown to what extent 10-year overall survival of radical nephrectomy treated intermediate/high-risk non-metastatic clear cell renal carcinoma patients differs from age- and sex-matched population-based controls, especially when...
6.
Jannello L, Baudo A, Scheipner L, de Angelis M, Siech C, Di Bello F, et al.
Int Urol Nephrol . 2024 Aug; 57(1):107-113. PMID: 39129040
Purpose: To quantify to what extent the 5-year overall survival (OS) of adrenocortical carcinoma (ACC) patients differs from age- and sex-matched population-based controls, especially when stage is considered. Methods: We...
7.
Alessi S, Maggioni R, Luzzago S, Summers P, Renne G, Zugni F, et al.
Radiol Med . 2024 Jul; 129(9):1394-1404. PMID: 39014292
Purpose: To assess the ability of tumor apparent diffusion coefficient (ADC) values obtained from multiparametric magnetic resonance imaging (mpMRI) to predict the risk of 5-year biochemical recurrence (BCR) after radical...
8.
Jannello L, Siech C, de Angelis M, Di Bello F, Penaranda N, Tian Z, et al.
Ann Surg Oncol . 2024 Jul; 31(9):5839-5844. PMID: 38980582
Background: Radiotherapy (RT) represents an alternative treatment option for patients with T1 squamous cell carcinoma of the penis (SCCP), with proven feasibility and tolerability. However, it has never been directly...
9.
Musi G, Mistretta F, Ivanova M, de Cobelli O, Bellin A, Vago G, et al.
BJU Int . 2024 Jun; 134(5):773-780. PMID: 38890817
Objectives: To test the performance of ex vivo fluorescence confocal microscopy (FCM; Vivascope 2500M-G4), as compared to intra-operative frozen section (IFS) analysis, to evaluate surgical margins during robot-assisted radical prostatectomy...
10.
Musi G, Vaccaro C, Luzzago S, Mauri G, Piccinelli M, Maiettini D, et al.
Clin Genitourin Cancer . 2024 May; 22(4):102109. PMID: 38820997
Objectives: To test for specific anthropometric parameters to predict perioperative outcomes after thermal ablation (TA) for renal cell carcinoma (RCC). Materials And Methods: Retrospective single center (2008-2022) analysis of 538...